# It’s not just the multinationals who are repurposing existing drugs to treat Covid-19. That’s what IIT-Hyderabadis hoping to do for Black Fungus, a fungal infection, witnessing an increased incidence across the country. This has caused a run on Amphotericin B injections, used to treat Black Fungus.
But researchers at the Indian Institute of Technology (Hyderabad) are optimistic that a tablet they had developed for Kala Azar, a fungal disease too, could well be used to treat Black Fungus patients.And the price of the tablet – about Rs 200 for 60 gms. Compare this to the injection, hovering around the Rs 6000 odd price range.
IIT-H researchers develop oral solution to treat black fungus
# Staying with research, a student from SRM university (AP) has received IP protection for a biodegradable face shield.
Student of SRM University, AP bags copyright for biodegradable face shield
# Hospitals have been ground-zero for treating the virus. Aster DM’s chief explains why its important to change the ventilating systems, when confronted with an air-borne virus.
Aster DM Healthcare to re-look at HVAC systems in hospitals
# Former FM Chidambaram has called for an audit to trace the “missing”vaccines.
Reveal the mystery of missing vaccines: Chidambaram
# Meanwhile, the Centre has discontinued Central allocation of anti-viral remdesivir, due to enhanced production and supply.
# As the pandemic takes a high toll, benefits have been announced for families of workers who died of Covid.
Pension, insurance benefits for families of workers who died due to Covid
# Internationally, the EU has now cleared vaccines for kids between 12 and 15 years – after the US, Canada and Singapore.
EU clears Pfizer vaccine for 12 -15-year olds
# The UK gets its fourth vaccine, as the MHRA approves the J&J vaccine.
# Students in Mumbai can walk-in and get vaccinated next week, if they are headed to a foreign university.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.